Instructions to Authors

INSTRUCTIONS TO AUTHORS

Istanbul University Journal of Pharmacy (Istanbul J. Pharm., IUJP) covers the research on all aspects of Pharmacy presented as original articles, short reports and reviews. It is formerly known as “The Journal of Faculty of Pharmacy of Istanbul University”.

Istanbul University Journal of Pharmacy is published three times (April, August, December) in a year. It is an open access and peer-reviewed journal.  

Original articles: These are limited to 15 typewritten pages in addition to supplementary materials (schemes, tables, figures, etc.).

Short papers: Short papers are limited to 5 typewritten pages and maximum of 2 supplementary materials (schemes, tables, figures).

Reviews: They are limited to 20 pages in addition to supplementary materials (schemes, tables, figures, etc.).


Article Submission

1) Contributions to Istanbul University Journal of Pharmacy must be in English.

2) All manuscript for Istanbul University Journal of Pharmacy should be submitted electronically through the website of the journal which can be accessed at http://istanbul.dergipark.org.tr/iujp

You will be guided stepwise through the creation and uploading of various files.

For further information please contact to the editor:

Prof.Dr. Emine AKALIN (Editor in Chief)

          jfacpharm@istanbul.edu.tr

        Istanbul University Journal of Pharmacy”    

        Istanbul University, Faculty of Pharmacy,

34116, Beyazıt-Istanbul / Turkey    


Prof.Dr. Emine AKALIN (Editor in Chief)

  jfacpharm@istanbul.edu.tr

         “Istanbul University Journal of Pharmacy”   

İstanbul Üniversitesi Eczacılık Fakültesi,

34116, Beyazıt-İstanbul / Türkiye  


3) All manuscripts are subject to editorial review.

4) The title, author/authors name, surname, affiliation and address, correspondence address and the type of the article should be written on a separate sheet and attached to the first page of the manuscript.

5) The manuscripts should not be previously published or accepted for publication and should not be submitted or under simultaneous consideration for publication elsewhere.  

6) The manuscripts are published in the order of final acceptance after review and revision.

7) If the manuscript is returned to authors for revision and the revised manuscript is not received by the editor within 2 months it will be treated as a new article.

8) If the manuscript is accepted and the proof is returned to the authors, corrected proofs should be sent to the editor within 3 days.


PREPARATION OF THE MANUSCRIPT


In order to achieve uniform presentation and to avoid unnecessary delays, authors are requested to observe the following principles:

The manuscript should be prepared in MS Word format by using Times New Roman font (12 pt) and double-spaced on one side of the paper with adequate margins (2.5 cm). Original drawings, figures, images etc. must be submitted with the original manuscript.

The original manuscript must be arranged as follows: Title page (including the title, authors and correspondence address), abstract, key words, introduction, materials and methods, results and discussion, acknowledgements and references.

The reviews must be arranged as follows: Title page (including the title, authors and correspondence address),   abstract, key words, introduction, discussion, acknowledgements and references.

Pages should be numbered starting from the abstract page.

Abbreviations must follow International rules and defined at their first mention in the text.

The symbols should be selected in accordance with the international usage and defined where it is first used.

Title Page

Title: Must be short and informative and written in bold uppercase letters.

Authors: Names and surnames of the authors will be written in capitalized letter for the first letter of each word and the address of the author(s) should be linked by superscript numbers, and listed beneath the title. Corresponding author must be indicated (*) in the author names.

Example: 


Studies on some azopyrazole derivatives (13 pt)


Nedime Ergenç1,*, Sevim Rollas2, Yalçın Topaloğlu3, Gültaze Çapan1 (11 pt)


1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, 34116 Istanbul, Turkey (10 pt)

    2 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, 34722 Istanbul, Turkey.

    3 Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, 34116 Istanbul, Turkey.


Correspondence: E-mail of the corresponding author is written (10 pt).


Abstract

Briefly give the objectives, methods, results and conclusions and it should not exceed 200 words (11 pt).

Key words

Authors must give 3- 6 key words which identify the subject covered by the paper (11 pt).

Introduction

Should indicate the subject of the article which is generally based on a brief interpretation of the related literature. The novelty and the aim of the study should be clearly stated.

Materials and Methods

This part contains a brief and clear description of the materials and methods used. Subtitles can be given as appropriate.

For clinical trials carried on humans by applying drugs, the authors should have the approvals of the related local Ethical Committee. The mentioned approval, the protocol made with the human volunteers and their consent for the studies should be attached and mentioned in this part of the manuscript.

For experimental studies carried on animals, the authors should mention whether the institutional and national guide for care and use of laboratory animals was respected and also indicate the approval of the local Ethical Committee in this part of the manuscript.

For plant materials, herbarium name (or acronym), number, name and surname of the person who identified the plant materials should be indicated in this part of the manuscript.

Statistical analysis of the data and descriptive details of the chemicals used should be explained briefly as a sub-title in this section.

Results and Discussion    (separate or together)

The data and results of the research (tables and figures) must be clearly and concisely defined and a comparison with related literature citations should be made as appropriate. Significant findings should be briefly summarized as a conclusion in the last paragraph.

Tables and Figures

Table and Figure titles should be short and informative (10 pt). Descriptive titles should be given at the top of the tables and at the bottom of the figures.  Tables and Figures should be numbered consequently in the order of appearance within the text, referred as “Table 1” and Figure 1”.  

Example:

Table 1. Purification of aspartate aminotransferase (AST) from the mantle tissue of M. galloprovincialis


Figures should be prepared with the highest resolution and embedded in the manuscript file.

While submission of the manuscript they should also be attached as separate files in “TIFF” or “JPEG” format.

Acknowledgements

Supporting institutions or individuals are briefly acknowledged (10 pt) just before the reference list.

References

Citation in the text should be by the author(s) surname and the publication date.

Examples:

(Ergenç 2000) – one author

(Ergenç and Rollas 2000) – two authors

(Ergenç et al. 2000) – more than two authors

(Ergenç and Rollas 2000a, b) – more than one paper in the same year by the same author (s)

(Ergenç and Rollas 2000; Ergenç et al. 2001; Ergenç 2005) – listed by the earliest year first for                                                                                                                       multiple citations.


The references must be listed alphabetically in the references section. The names of the journals should be written in italics and volume numbers should be indicated in bold letters (10 pt).

Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations.  The correctness of the references is belong to the authors.

Examples:

Journal article: Orlacchio A, Campos-Cavieres M, Pashev I, Munn EA (1979). Some kinetic and other properties of the isoenzymes of aspartate aminotransferase isolated from sheep liver. Biochem J 177: 583-593.

Article by DOI: Ermut G, Karalı N, Özsoy N, Can A (2014). New spiroindolinones bearing 5-chlorobenzothiazole moiety. J Enzyme Inhib Med Chem   doi: 10.3109/14756366.2013.800058.

Book: Bremer K (1994). Asteraceae: Cladistics and Classification. 1st ed, Timber Press, USA.

Book chapter: Benn MH, Jacyno JM (1983). The toxicology and pharmacology of diterpenoid alkaloids. In: Pelletier SW (ed./eds.) Alkaloids: Chemical and Biological Perspectives, Vol. 1, John Wiley & Sons, New York, pp. 153-210.

Dissertation (Thesis): Demirci S (2010). Andırın (Kahramanmaraş) İlçesinde Etnobotanik Bir Araştırma. Unpublished MSc Thesis, Istanbul University, Istanbul.

Research Report:  Özhatay N, Akalın E, Yeşil Y, Demirci S, Güler N, Ersoy H (2010). Flora of Yıldız Mountains (Yıldız Mountains Biosphere Project Report Series No. 3), Prepared for the Ministry of Environment and Forestry, Ankara.

http://yildizdaglari.cevreorman.gov.tr/medialibrary/2010/07/Flora_full_report_en.pdf.

UNEP-WCMC (2009) Species suggested for review on the basis of the Analysis of 2007 (EC annual reports, SGR 49/8/3), Prepared for the European Commission. UNEP-WCMC, Cambridge.

Electronic resources: (2014) World Nuclear Association. Radioisotopes in Medicine, http://www.world-nuclear.org/info/inf55.html,www.world-nuclear.org/info/inf55.html. Accessed 13.10.2014.

Treglia G, Ceriani L, Sadeghi R, Giovacchini G, Giovanella, L. (2014) Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: A meta-analysis, Cli Chem Lab Med. http://www.reference-global.com/toc/cclm/current Accessed 16.09.2014.



Son Güncelleme Zamanı: 7.09.2020 16:59:59